| Dr Aaron Keith Starbuck, MD | |
|
575 S State St, Orem, UT 84058-6303 | |
| (801) 225-2926 | |
| (801) 229-2420 |
| Full Name | Dr Aaron Keith Starbuck |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 21 Years |
| Location | 575 S State St, Orem, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336288034 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 04-31154 (Kansas) | Secondary |
| 207Q00000X | Family Medicine | 062609 (Georgia) | Secondary |
| 207Q00000X | Family Medicine | 349048-1205 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Utah Clinic Pc | 7517868508 | 391 |
News Archive
Because the severe autism-like condition Christianson Syndrome was only first reported in 1999 and some symptoms take more than a decade to appear, families and doctors urgently need fundamental information about it. A new study that doubles the number of cases now documented in the scientific literature provides the most definitive characterization of CS to date.
A third of Ohio children with special health care needs have unstable or inadequate insurance coverage despite the fact that they may qualify for government health programs, according to a new data analysis by the Child Policy Research Center at Cincinnati Children's Hospital Medical Center.
The latest issue of Seattle magazine names 36 physicians within the EvergreenHealth network to the publication's annual "Top Doctors" list.
Alkermes, Inc. today announced positive preliminary results from a phase 3 clinical trial of naltrexone for extended-release injectable suspension (XR-NTX) for the treatment of opioid dependence. The six-month phase 3 study met its primary efficacy endpoint and data showed that patients treated once-monthly with XR-NTX demonstrated statistically significant higher rates of clean (opioid-free) urine screens, compared to patients treated with placebo, as measured by the cumulative distribution of clean urine screens (p<0.0002).
› Verified 9 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Because the severe autism-like condition Christianson Syndrome was only first reported in 1999 and some symptoms take more than a decade to appear, families and doctors urgently need fundamental information about it. A new study that doubles the number of cases now documented in the scientific literature provides the most definitive characterization of CS to date.
A third of Ohio children with special health care needs have unstable or inadequate insurance coverage despite the fact that they may qualify for government health programs, according to a new data analysis by the Child Policy Research Center at Cincinnati Children's Hospital Medical Center.
The latest issue of Seattle magazine names 36 physicians within the EvergreenHealth network to the publication's annual "Top Doctors" list.
Alkermes, Inc. today announced positive preliminary results from a phase 3 clinical trial of naltrexone for extended-release injectable suspension (XR-NTX) for the treatment of opioid dependence. The six-month phase 3 study met its primary efficacy endpoint and data showed that patients treated once-monthly with XR-NTX demonstrated statistically significant higher rates of clean (opioid-free) urine screens, compared to patients treated with placebo, as measured by the cumulative distribution of clean urine screens (p<0.0002).
› Verified 9 days ago
| Entity Name | Central Utah Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093764805 PECOS PAC ID: 7517868508 Enrollment ID: O20040113000805 |
News Archive
Because the severe autism-like condition Christianson Syndrome was only first reported in 1999 and some symptoms take more than a decade to appear, families and doctors urgently need fundamental information about it. A new study that doubles the number of cases now documented in the scientific literature provides the most definitive characterization of CS to date.
A third of Ohio children with special health care needs have unstable or inadequate insurance coverage despite the fact that they may qualify for government health programs, according to a new data analysis by the Child Policy Research Center at Cincinnati Children's Hospital Medical Center.
The latest issue of Seattle magazine names 36 physicians within the EvergreenHealth network to the publication's annual "Top Doctors" list.
Alkermes, Inc. today announced positive preliminary results from a phase 3 clinical trial of naltrexone for extended-release injectable suspension (XR-NTX) for the treatment of opioid dependence. The six-month phase 3 study met its primary efficacy endpoint and data showed that patients treated once-monthly with XR-NTX demonstrated statistically significant higher rates of clean (opioid-free) urine screens, compared to patients treated with placebo, as measured by the cumulative distribution of clean urine screens (p<0.0002).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron Keith Starbuck, MD 1055 N 500 W, Attn: Credentialing, Provo, UT 84604-3305 Ph: (801) 354-8225 | Dr Aaron Keith Starbuck, MD 575 S State St, Orem, UT 84058-6303 Ph: (801) 225-2926 |
News Archive
Because the severe autism-like condition Christianson Syndrome was only first reported in 1999 and some symptoms take more than a decade to appear, families and doctors urgently need fundamental information about it. A new study that doubles the number of cases now documented in the scientific literature provides the most definitive characterization of CS to date.
A third of Ohio children with special health care needs have unstable or inadequate insurance coverage despite the fact that they may qualify for government health programs, according to a new data analysis by the Child Policy Research Center at Cincinnati Children's Hospital Medical Center.
The latest issue of Seattle magazine names 36 physicians within the EvergreenHealth network to the publication's annual "Top Doctors" list.
Alkermes, Inc. today announced positive preliminary results from a phase 3 clinical trial of naltrexone for extended-release injectable suspension (XR-NTX) for the treatment of opioid dependence. The six-month phase 3 study met its primary efficacy endpoint and data showed that patients treated once-monthly with XR-NTX demonstrated statistically significant higher rates of clean (opioid-free) urine screens, compared to patients treated with placebo, as measured by the cumulative distribution of clean urine screens (p<0.0002).
› Verified 9 days ago
Abraham R Tomco, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 W 800 N, Suite 220, Orem, UT 84057 Phone: 801-354-8205 Fax: 801-354-8206 | |
Darrell R Stacey, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 505 W 400 N, Orem, UT 84057 Phone: 801-714-3450 | |
Joseph C Bingham, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 505 W 400 N, Orem, UT 84057 Phone: 801-714-3450 | |
Randy L Rogers, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 W 400 N, Orem, UT 84057 Phone: 801-714-3450 | |
Emily Elizabeth Robbins, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 W 800 N Ste 220, Orem, UT 84057 Phone: 801-354-8205 Fax: 801-354-8206 | |
Andrew Chilberg Judd, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1975 N State St, Orem, UT 84057 Phone: 801-714-5500 | |
Dr. Jennifer Sariah Gilbert, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1975 N State St, Orem, UT 84057 Phone: 801-714-5000 |